Preliminary
Does Ginseng Slow Aging? A Small Study on Telomeres and Cellular Energy in Middle-Aged Adults

Ginseng showed associations with longer telomeres and better aging markers in this small uncontrolled study, but without a placebo group or independent replication, these findings are preliminary and could reflect …

41 /100
No control or placebo arm (major limitation for self-reported outcomes and biomarker changes). Small sample sizes (n=20 and n=30). No …
Preliminary
How Mild Calorie Restriction Rewires Brown Fat to Stay Energetic

Mild calorie restriction rewires brown fat to work more efficiently—not by burning out, but by adapting its metabolism while preserving its heat-generating power. This is a mechanistic clue about why …

40 /100
Animal model only (rats); very short intervention (2 weeks) with unknown long-term effects; male animals only; sample size not reported …
Preliminary
How aging immune cells drive aging throughout the body

This is an authoritative but not definitive review explaining why your immune system's aging is a central driver of whole-body aging—and why fixing it could be unexpectedly powerful for extending …

45 /100
This is a review article, not a primary research study, so it presents no new experimental data. The credibility depends …
Preliminary
Can crocin-enriched tomatoes slow aging and protect the brain?

This fruit fly study suggests crocin-enriched tomatoes may protect aging brains by supporting mitochondria, but much more work—especially human studies—is needed before we can say whether eating these tomatoes will …

37 /100
Sample sizes not clearly reported in abstract; first publication with zero citations (no replication yet); animal model only (Drosophila findings …
Preliminary
How to Reverse Age-Related Immune System Decline

This is a well-informed roadmap of how to potentially reverse immune aging by restoring the thymus gland, but it's mostly a survey of promising ideas rather than proof of what …

40 /100
Review article with zero citations—community validation pending. Most interventions discussed lack human clinical trial data; evidence is primarily preclinical. Publication …
Preliminary
A Protein That Blocks Exercise Benefits: Why Some People Don't Respond to Training

This preprint identifies an intriguing protein that may explain why some people gain fitness from exercise while others don't—a finding with potential longevity implications. However, it's early-stage research that needs …

25 /100
Preprint with no peer review. Human trial sample size not disclosed in abstract (critical omission). Zero citations—no independent replication. Observational …
Preliminary
New Drug Candidate 28i Shows Promise for Slowing Aging in Animal Models

This is promising preclinical drug discovery work showing a new compound can slow aging in worms and mice without the side effects of its parent drug. However, it remains early-stage …

39 /100
Publication date listed as February 2026 (future date) is highly unusual and suggests either data error or unclear publication status. …
Preliminary
How Aging Drives Alzheimer's Disease: A Molecular Roadmap

This paper presents a compelling framework showing how aging itself drives Alzheimer's disease through multiple interconnected pathways, suggesting that slowing aging might prevent AD. However, this is a synthesis of …

37 /100
This is a review article with no primary data—it does not report original experiments or clinical trials. No citations yet …
Preliminary
Reversing liver scarring with reprogramming mRNA in mice

This is promising early-stage lab research showing that specially designed mRNA can coax scarred liver cells back toward a youthful, healing state in mice—a novel proof-of-concept. However, it's far too …

41 /100
Early preclinical work in mouse model only; no human data or clinical trials announced. Citation count is zero—awaiting independent peer …
Preliminary
A metabolomic clock predicts aging and disease risk across two populations

This preprint presents a promising new 'metabolomic aging clock' that tracks how fast people's bodies are aging at a molecular level and links it to mortality and disease—but because it …

39 /100
Preprint status: not yet peer-reviewed. No mention of data availability, trial preregistration, or conflicts of interest in abstract. Observational/associational design …